secwatch.observer — SEC 8-K summary
======================================

Issuer:     Nuvation Bio Inc. (NUVB)
CIK:        0001811063
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001193125-25-125763
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Nuvation Bio stockholders elect directors, ratify auditor, approve say-on-pay at 2025 annual meeting
--------------------------------------------------------------------------------

- All three proposals passed at May 21, 2025 annual meeting; quorum of 82.8% of Class A shares present.
- Kathryn E. Falberg elected Class A director with 198.6M for, 18.0M withheld; David Hung elected Class B director with 1.0M for.
- Ratification of KPMG LLP as auditor for FY2025: 279.9M for, 1.6M against, 15.8K abstain.
- Advisory approval of named executive officer compensation: 214.9M for, 1.6M against, 143.8K abstain.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811063/000119312525125763/0001193125-25-125763-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811063/000119312525125763/d908097d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-125763

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer